Emcure Pharmaceuticals
EMCURE · Pharma > Pharmaceuticals & Drugs Listing date: July 10, 2024

Stock Price vs Company Growth
1d
2.8%
1w
2.5%
1m
8.5%
3m
2.8%
all
4.9%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,425 2.8%
1,279
1,530
Company Overview

Sales
7,036 Cr
Growth: 13.0%
Profit after Tax
608 Cr
Growth: 11.8%
Mid Cap
26,992 Cr
P/E: 42.9x
Industry P/E: 37.1x
Fundamentals

Sales (Cr) ₹ 7,036
Growth 13.0%
EBITDA 19.1%
P/S 3.8x
Dividend 0.0%
P/E 42.9x
Book Value ₹ 9.98
PEG Ratio 3.3x
ROE 332.4%
P/B N/A
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company’s core strength and competitive advantage lie in its established presence in all major therapeutic areas including Gynaecology, cardiology, blood-related, oncology, respiratory, CNS & HIV among others.